All In Biotech

Drug Trial Radar · NCT07383441

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

Phase III Double Blinded Trial of Immune-Based Therapy With a Live Biotherapeutic MO-03 or Placebo for Frontline Therapy of Advanced Clear Cell Renal Cell Carcinoma [BioFront Trial]

Last checked: Nov 19, 2026Latest source record: Jun 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 718 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

718

Planned (sponsor's estimate)

Start

Jun 5, 2026

Primary completion

Jan 31, 2033

Study completion Jan 31, 2034

Sponsor

Lead sponsor
SWOG Cancer Research NetworkResearch network
Sponsor type
Research network
Collaborators
National Cancer Institute (NCI)
First posted
Feb 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, care provider)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial compares the effect of adding live biotherapy, MO-03, to standard of care (SOC) immunotherapy, including ipilimumab, nivolumab, axitinib, pembrolizumab, cabozantinib, and lenvatinib, to SOC immunotherapy alone in treating patients with clear cell renal cell cancer that may have spread from where it first started (primary site) to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started to other places in the body (metastatic). Studies have shown that gut health (the gut microbiome) may impact the effectiveness of immunotherapy. The microbiome includes all of the bacteria and organisms naturally found in the digestive tract. MO-03, a type of biotherapy, contains material from living organisms that may help keep the digestive tract healthy and may help to increase the effect of immunotherapy. Immunotherapy with monoclonal antibodies, such as ipilimumab, nivolumab, pembrolizumab, may help the body's immune system attack the tumor, and may interfere with the ability of tumor cells to grow and spread. Axitinib, cabozantinib, and lenvatinib are a type of angiogenesis inhibitor and tyrosine kinase inhibitor (TKI) that block certain proteins which may help keep tumor cells from growing and may also help prevent the growth of new blood vessels that tumors need to grow. Adding MO-03 to SOC immunotherapy may be more effective than SOC immunotherapy alone in treating patients with advanced or metastatic clear cell renal cell cancer.

Conditions

  • Advanced Clear Cell Renal Cell Carcinoma
  • Metastatic Clear Cell Renal Cell Carcinoma
  • Stage III Renal Cell Cancer AJCC v8
  • Stage IV Renal Cell Cancer AJCC v8

Interventions

  • AxitinibDrug

    Given PO

  • Biospecimen CollectionProcedure

    Undergo blood sample collection

  • Bone ScanProcedure

    Undergo bone scan

  • CabozantinibDrug

    Given PO

  • Clostridium butyricum CBM 588 Probiotic StrainDrug

    Given PO

  • Computed TomographyProcedure

    Undergo CT

  • IpilimumabBiological

    Given IV

  • LenvatinibDrug

    Given PO

  • Magnetic Resonance ImagingProcedure

    Undergo MRI

  • NivolumabBiological

    Given IV

  • Nivolumab and Recombinant Human HyaluronidaseDrug

    Given SC

  • PembrolizumabBiological

    Given IV

  • Placebo AdministrationDrug

    Given PO

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Progression-free survival (PFS)Time frame: From date of randomization to date of first documentation of progression, or death due to any cause, assessed up to 5 years

Locations

41 sites in 1 country. Site status is shown where the registry gives one.

  • Highlands Oncology Group - Fayetteville

    Fayetteville, Arkansas · Recruiting

  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro

    Jonesboro, Arkansas · Recruiting

  • Highlands Oncology Group - Rogers

    Rogers, Arkansas · Recruiting

  • Highlands Oncology Group

    Springdale, Arkansas · Recruiting

  • Illinois CancerCare-Bloomington

    Bloomington, Illinois · Recruiting

  • Illinois CancerCare-Canton

    Canton, Illinois · Recruiting

  • Illinois CancerCare-Carthage

    Carthage, Illinois · Recruiting

  • Cancer Care Specialists of Illinois - Decatur

    Decatur, Illinois · Recruiting

  • Decatur Memorial Hospital

    Decatur, Illinois · Recruiting

  • Illinois CancerCare-Eureka

    Eureka, Illinois · Recruiting

  • Illinois CancerCare-Galesburg

    Galesburg, Illinois · Recruiting

  • Illinois CancerCare-Kewanee Clinic

    Kewanee, Illinois · Recruiting

  • Illinois CancerCare-Macomb

    Macomb, Illinois · Recruiting

  • Illinois CancerCare-Ottawa Clinic

    Ottawa, Illinois · Recruiting

  • Illinois CancerCare-Pekin

    Pekin, Illinois · Recruiting

  • Illinois CancerCare-Peoria

    Peoria, Illinois · Recruiting

  • Illinois CancerCare-Peru

    Peru, Illinois · Recruiting

  • Illinois CancerCare-Princeton

    Princeton, Illinois · Recruiting

  • Southern Illinois University School of Medicine

    Springfield, Illinois · Recruiting

  • Illinois CancerCare - Washington

    Washington, Illinois · Recruiting

  • Mercy Hospital

    Cedar Rapids, Iowa · Recruiting

  • Oncology Associates at Mercy Medical Center

    Cedar Rapids, Iowa · Recruiting

  • Lahey Hospital and Medical Center

    Burlington, Massachusetts · Recruiting

  • Lahey Medical Center-Peabody

    Peabody, Massachusetts · Recruiting

  • Trinity Health IHA Medical Group Hematology Oncology - Brighton

    Brighton, Michigan · Recruiting

  • Trinity Health IHA Medical Group Hematology Oncology - Canton

    Canton, Michigan · Recruiting

  • Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

    Chelsea, Michigan · Recruiting

  • Trinity Health Saint Mary Mercy Livonia Hospital

    Livonia, Michigan · Recruiting

  • Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

    Ypsilanti, Michigan · Recruiting

  • Baptist Memorial Hospital and Cancer Center-Golden Triangle

    Columbus, Mississippi · Recruiting

  • Baptist Cancer Center-Grenada

    Grenada, Mississippi · Recruiting

  • Baptist Memorial Hospital and Cancer Center-Union County

    New Albany, Mississippi · Recruiting

  • Baptist Memorial Hospital and Cancer Center-Oxford

    Oxford, Mississippi · Recruiting

  • Baptist Memorial Hospital and Cancer Center-Desoto

    Southhaven, Mississippi · Recruiting

  • Saint Francis Medical Center

    Cape Girardeau, Missouri · Recruiting

  • Parkland Health Center - Farmington

    Farmington, Missouri · Recruiting

  • Sainte Genevieve County Memorial Hospital

    Sainte Genevieve, Missouri · Recruiting

  • Missouri Baptist Medical Center

    St Louis, Missouri · Recruiting

  • Missouri Baptist Sullivan Hospital

    Sullivan, Missouri · Recruiting

  • Baptist Memorial Hospital and Cancer Center-Collierville

    Collierville, Tennessee · Recruiting

Showing 40 of 41 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.